GlobeNewswire

Nexstim Pre-Surgical Mapping Technology Covered in over 100 Scientific Articles

Share

Press Release, Helsinki, 10 September 2020 at 11.00 am (EEST)

Nexstim Pre-Surgical Mapping Technology Covered in over 100 Scientific Articles

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that the number of scientific articles covering patients undergoing pre-operative mapping with Nexstim’s NBS System prior to neurosurgery has exceeded 100.

Nexstim’s NBS System with SmartFocus® nTMS is the only FDA cleared nTMS system for non-invasive mapping of the motor and speech cortices of the brain. It has been the subject of intensive research since its early days and is now extensively covered in over 100 peer-reviewed articles on the treatment planning of both neurosurgery and radiotherapy.

Nexstim NBS System with SmartFocus ® TMS technology is used in diagnostics: For example, when a patient has a diagnosis of a brain tumour or other disorder, brain mapping can define how close the lesion resides in relation to vital functional areas of the brain – such as those responsible for speech production and limb movement. Brain maps from NBS can be invaluable when deciding the best treatment option for the patient.

Jarmo Laine, MD, VP of Medical Affairs at Nexstim commented: “Nexstim’s NBS System with SmartFocus® nTMS is best known for use prior to tumour surgery, but it is used also for planning epilepsy and arteriovenous malformation (AVM) surgery and radiotherapy. These applications are extensively reported in these publications from world-leading institutions covering the full range from initial proof of concept to large multi-center studies in hundreds of patients”

In addition to over 100 publications related to pre-operative mapping, there are also several publications involving applications, such as spinal pathologies, that are not yet clinically validated and approved for Nexstim NBS System.

Mikko Karvinen, CEO of Nexstim, said: “We are committed to offering technology solutions solidly grounded in scientific and clinical research. Exceeding 100 publications only in the field of pre-operative mapping emphasises this commitment. We want to thank all of the research teams that have helped develop this technology and continue to help find new users for the NBS systems. The variety of topics in these scientific publications highlight that SmartFocus® nTMS can be invaluable also when planning other brain surgeries than only those related to tumours.”

Links to most of the articles and studies can be found on www.nexstim.com/research/literature/

Further information is available on the website www.nexstim.com, or by contacting:

Mikko Karvinen, CEO
+358 50 326 4101
mikko.karvinen@nexstim.com

About Nexstim Plc

Nexstim is a Finnish, globally operating medical technology company. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders.

Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain.

SmartFocus® technology is used in Nexstim’s proprietary Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT® system is CE marked for the treatment of major depression and chronic neuropathic pain.

In addition, Nexstim is commercializing its SmartFocus® based Navigated Brain Stimulation (NBS) system for diagnostic applications. The NBS system is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain. Nexstim shares are listed on the Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden.

For more information please visit www.nexstim.com

Attachment

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

NAXS har gjort ett investeringsåtagande till Nordic Capital Fund X1.10.2020 21:00:00 CESTPressemelding

NAXS har gjort ett åtagande till Nordic Capital Fund X (“Fonden”), den tionde fonden som rests av Nordic Capital. Med en storlek om 6,1 Mdr SEK är fonden den största som Nordic Capital etablerat sedan verksamheten grundades 1989. Fondresningen inleddes under april 2020, tog mindre än 6 månader och när fonden nådde sin maximala storlek (”hard cap”) var den kraftigt övertecknad. Fonden kommer att investera enligt Nordic Capitals strategi att göra majoritetsinvesteringar i icke-cykliska tillväxtföretag inom sektorerna Healthcare, Technology & Payments och Financial Services. NAXS är sedan tidigare investerare i Nordic Capital Fund VII och Nordic Capital CV1. Ytterligare information kommer vara tillgänglig i NAXS Q3 rapport som publiceras den 20 oktober. Kontaktinformation Lennart Svantesson, verkställande direktör Telefon: +46 73 311 00 11 Informationen lämnades, genom ovanstående kontaktpersons försorg, för offentliggörande den 1 oktober 2020 kl. 21.00. Pressmeddelanden och ytterligare i

NAXS has made an investment commitment to Nordic Capital Fund X1.10.2020 21:00:00 CESTPress release

Not for release, publication or distribution, directly or indirectly, in or into the United States, Hong Kong, Canada, Japan or Australia, or any other jurisdiction in which the distribution or release would be unlawful. NAXS has made an investment commitment to Nordic Capital Fund X (the “Fund”), the tenth fund raised by Nordic Capital. At EUR 6.1 billion, the Fund is the largest that Nordic Capital has raised since its inception in 1989. The Fund, launched in April 2020, was oversubscribed at its hard cap, and was raised in less than 6 months. The Fund is set to continue Nordic Capital’s successful strategy of focusing on majority investments in non-cyclical growth companies in the Healthcare, Technology & Payments and Financial Services sectors. NAXS is an investor in Nordic Capital Fund VII and Nordic Capital CV1. More information will be available in NAXS’s Q3 2020 report, due October 20th. Contact information: Lennart Svantesson, CEO Telephone: +46 73 311 00 11 This information w

Major shareholder announcement – NOVO HOLDINGS A/S1.10.2020 20:16:07 CESTPress release

Company announcement 16-2020, COPENHAGEN, DENMARK Pursuant to Section 38 of the Danish Capital Markets Act, FLSmidth has been informed that NOVO HOLDINGS A/S has reduced his holding of FLSmidth shares to a total 2,455,584 FLSmidth & Co. A/S shares, which corresponds to 4.79% of the total nominal share capital and voting rights in FLSmidth & Co. A/S. Contacts Media Relations Rasmus Windfeld, +45 40 44 60 60, rwin@flsmidth.com Investor Relations Nicolai Mauritzen, +45 30 93 18 51, nicm@flsmidth.com FLSmidth provides sustainable productivity to the global mining and cement industries. We deliver market-leading engineering, equipment and service solutions that enable our customers to improve performance, drive down costs and reduce environmental impact. Our operations span the globe and our 11,765 employees are present in more than 60 countries. In 2019, FLSmidth generated revenue of DKK 20.6 billion. www.flsmidth.com Attachment Company announcement 16 Novo HOLDINGS

RCI Banque : PLACEMENT OF A 991.5 MILLION EURO SECURITIZATION BACKED BY FRENCH AUTO LEASES WITH PURCHASE OPTION “LOA”1.10.2020 19:18:09 CESTPress release

October 1st, 2020 PLACEMENT OF A 991.5 MILLION EURO SECURITIZATION BACKED BY FRENCH AUTO LEASES WITH PURCHASE OPTION “LOA” RCI Bank and Services announces the placement of its first securitization backed by auto lease monthly instalments (residual value component excluded) originated by its French subsidiary DIAC. FCT Cars Alliance Auto Leases V 2020-1 has placed 950m€(1) of Senior notes and 41.5m€ of Junior notes. These notes are rated AAA(sf) / Aaa(sf) and AA (low)(sf) / Aa3(sf) respectively by DBRS and Moody’s. The Senior tranche, with a WAL of 2.9 years, has a margin(2) of Euribor 1 month + 23bps. The Junior notes, with a WAL of 4.5 years, have a margin of Euribor 1 month + 100bps. This issuance is the Group first public lease ABS and a key milestone in its funding diversification policy. The success of this transaction demonstrates investors’ confidence in the quality of RCI assets and its servicing process. This transaction also confirms the diversified financing sources to which

PILLAR III RISK REPORT AS OF DECEMBER 31, 2019 (AMENDED VERSION DATED 2020-10-01)1.10.2020 19:00:00 CESTPress release

Thursday, October 1st, 2020 PILLAR III RISK REPORT AS OF DECEMBER 31, 2019 (AMENDED VERSION DATED 2020-10-01) An amended version of the Pillar III report as of 12/31/2019 is available on our website rcibs.com under the reference “PILLAR 3 DISCLOSURES 2019-12-31 (AMENDED VERSION DATED 2020-10-01)”. Changes versus initial release are listed below: Correction on own funds, total capital ratio, CET1 ratio, leverage ratio initially reported to reflect the cancellation of € 300 million planned dividend in respect of 2019 results. Such decision has been announced in our press release dated April 23, 2020 and intended to comply with ECB recommendations on dividend payments. Error corrections on tables IX-2 AE1 “Encumbered and unencumbered assets” and IX-3 AE2 “Collateral received” in page 85 and 86. This new version cancels and replaces Pillar III report published on our website on a stand-alone basis on 30/3/2020 and integrated in our annual report published on 29/04/2020. Contact Analysts an